Jefferies Financial Group Boosts Boston Scientific Holdings

Investment firm increases stake in medical device company by 17.4% in Q3

Published on Mar. 9, 2026

Jefferies Financial Group Inc. has increased its holdings in Boston Scientific Corporation (NYSE:BSX) by 17.4% in the third quarter, according to a recent SEC filing. The investment firm now owns 302,499 shares of the medical equipment provider's stock, valued at $29.5 million at the end of the reporting period.

Why it matters

This investment move by Jefferies Financial Group suggests the firm sees strong potential in Boston Scientific's future performance. As a major institutional investor, Jefferies' increased stake could signal growing confidence in the medical device company's outlook among Wall Street analysts and investors.

The details

According to the 13F filing, Jefferies Financial Group purchased an additional 44,860 shares of Boston Scientific during the third quarter. The firm's total holdings in the company are now valued at $29.5 million. Boston Scientific is a major manufacturer of medical devices and equipment used in various minimally invasive procedures.

  • Jefferies Financial Group increased its Boston Scientific holdings in the third quarter of 2026.

The players

Jefferies Financial Group Inc.

A global investment banking firm that provides a full range of investment banking, advisory, sales and trading, research and asset management services.

Boston Scientific Corporation

A leading medical device company that develops, manufactures and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

Jefferies Financial Group's increased stake in Boston Scientific suggests the investment firm sees strong growth potential for the medical device company. This move could signal broader confidence on Wall Street in Boston Scientific's future performance and competitive position in the evolving healthcare technology market.